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BMD correlated with anthropometry and physical activity 
but not with calcium dietary intake. IHC children had lower 
whole-body BMD z-scores compared to controls. The role of 
IHC in reducing the whole-body BMD z-score was still sig-
nificant even when anthropometry, physical activity, and 
calcium intake were included as confounders in multivari-
ate analyses.  Conclusions: The prevalence of IHC in this 
population of 7-year-old children was about 17%. IHC diag-
nosis was associated with lower BMD z-scores and osteope-
nia in 22% of them.  © 2014 S. Karger AG, Basel 
 Introduction 
 The clinical consequences of adverse bone health are 
largely seen in old age; however, there is compelling evi-
dence that many predisposing factors to osteoporosis 
arise in childhood. It is known that bone remains meta-
bolically active throughout life and is subject to a con-
tinuous remodeling process. Thus, it is very important to 
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 Abstract 
 Background: Idiopathic hypercalciuria (IHC), i.e. an elevat-
ed urinary calcium excretion without concomitant hyper-
calcemia, is a common disorder in children and can have a 
range of urinary clinical presentations and decreased bone 
mineral density (BMD).  Aim: To assess the effect of IHC on 
bone mineral content in children without urological symp-
toms.  Methods: Calcium excretion, BMD (by dual-energy X-
ray absorptiometry), and anthropometry were assessed in 
175 seven-year-old children who were classified as IHC or 
controls. Calcium intake and physical activity were mea-
sured as confounding factors.  Results: The prevalence of 
IHC was 17.7%. Both groups (controls and IHC) showed sim-
ilar baseline characteristics in terms of their anthropometry, 
gender distribution, and protein and calcium dietary intakes 
as well as physical activity scores. Urinary calciuria was inde-
pendent of the calcium dietary intake and anthropometry. 
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gain an adequate bone mineral content (BMC) during fe-
tal development  [1] , childhood, and especially adoles-
cence, which is a critical period for BMC acquisition  [2, 
3] . Some studies have estimated that an increase in total 
mineral content of 10% at its peak predicts a delay of 13 
years in the onset of osteoporosis  [4] . Genetic endow-
ment, age, and gender, which are nonmodifiable factors, 
may explain up to 80% of the bone mass  [5, 6] . However, 
there are other factors that may influence bone mass ac-
cretion, such as sun exposure  [7] , hormones  [8] , physical 
exercise  [9] , several chronic diseases  [10] , and diet  [1, 11] 
(mainly the calcium intake)  [12] . 
 One specific disease that can influence bone health is 
idiopathic hypercalciuria (IHC). IHC, defined as an ele-
vated urinary calcium excretion without concomitant hy-
percalcemia, is a common disorder related to kidney li-
thiasis  [13] . In children, hypercalciuria (HC) can cause a 
wide range of symptoms, the most common being recur-
rent macroscopic or microscopic hematuria. Other com-
mon manifestations in children are frequency-dysuria 
syndrome, recurrent urinary infections, and abdominal 
and lumbar pain. HC has also been associated with a de-
creased bone mineral density (BMD)  [14] . Several au-
thors have found that up to 20–30% of children with HC 
have a reduced BMD  [15] ; the impact is stronger when 
HC is persistent and is present in older children  [16–18] . 
However, IHC may be asymptomatic during the first de-
cades of life, and thus IHC children could remain undi-
agnosed for long periods. If HC is a deleterious factor for 
bone health, then screening for this condition in school-
aged children becomes important. The aim of this study 
was to assess the effect of IHC on bone health in a homo-
geneous sample of prepubertal children, controlling for 
calcium intake, anthropometric characteristics, and 
physical activity.
 Subjects and Methods 
 Subjects 
 Children were recruited from the Spanish subsample of the EU 
Childhood Obesity Programme (CHOP) at 7 years of age. This 
study is an ongoing European collaborative prospective investiga-
tion of the long-term consequences of different protein intakes 
during the first year of life in 5 European countries (Belgium, Ger-
many, Italy, Poland, and Spain)  [19] . The aim of this study was to 
evaluate the influence of protein intake during the first year of life 
on the development of later obesity. For the present subanalysis, 
all children with a clinical history of urinary tract infection, hema-
turia, renal colic, flank pain, urolithiasis, or treatment with any 
drug with an action on calcium metabolism were excluded. The 
family history of urolithiasis was also recorded.
 Measurements 
 Anthropometry 
 The nude weight and length of the children were determined 
using a SECA 701 scale (precision: ±0.05 kg; SECA, Hamburg, 
Germany) and a SECA 242 stadiometer (precision: ±2 mm), re-
spectively. The body mass index [BMI = weight (kg)/length (m) 2 ] 
was calculated. For analysis, z-scores were calculated according to 
World Health Organization (WHO) standards  [20, 21] using 
WHO programs  [22] .
 Dietary Intake 
 Calcium (mg/day) intakes were assessed via a food frequency 
consumption questionnaire. The questionnaire contained 19 
items corresponding to milk and dairy foods. The habitual portion 
and frequency of consumption during the last month (times/day, 
times/week, or times/month) for each food item were recorded. All 
of the questionnaires were checked and entered into the databases 
by trained nutritionists. Nutritional contents were derived from 
either producers or national food databases  [23, 24] . The calcium 
intake (mg/day × kg of body weight) was obtained as the total cal-
cium intake, the calcium intake from milk, and the calcium intake 
from dairy products. To assess the role of the current dietary pro-
tein on urinary calcium excretion, we measured urea excretion as 
an indicator of the protein intake  [25, 26] .
 Physical Activity 
 Physical activity was evaluated using the Physical Activity 
Questionnaire (PAQ-C) as defined by Kowalski et al.  [27, 28] . The 
PAQ-C is a self-administered, 7-day recall questionnaire that mea-
sures general moderate-to-vigorous physical activity levels during 
the school year. It includes leisure time and daily physical activities 
as well as regular sports practices. We used physical activity as a 
confounding factor for BMD.
 IHC Screening and Urinalysis 
 Two urine samples 1 week apart on a second morning mictu-
rition were obtained for HC screening after a standardized 
breakfast that contained dairy products (equivalent in calcium 
content to 200 cm 3 of whole cow’s milk). Samples were collected 
and preserved at refrigeration temperatures until analyses (4–
8   °   C). A dipstick was used to exclude the presence of an overt 
urinary tract infection or hematuria in every collected sample. 
Following the criteria reported by Stapleton et al.  [29] , HC was 
diagnosed when the value of the calcium-to-creatinine ratio 
(UCa/UCr) was elevated in both urine collections; the HC diag-
nosis was made based on UCa/UCr (mg/mg) values above 0.21. 
The cutoff criterion for an HC diagnosis was the 95th percentile 
value of urinary calcium excretion for a Caucasian population of 
7 years of age  [30] . If the values of the first 2 samples were dis-
cordant, a third urine sample was collected the following week 
and analyzed to define the final classification. Urea, creatinine, 
and calcium were determined using standardized methods. Cal-
cium (mg/dl) was measured after acidification of the urine sam-
ple, adding HCl 6N to obtain a pH below 2, to dissolve the pre-
cipitated calcium. Urinary creatinine (mg/dl) was analyzed using 
the kinetic Jaffe reaction in an automated ADVIA 1650/Mega 
Bayer R (Leverkusen, Germany) in accordance with standard-
ized protocols. Urea was measured with reagents from Beckman-
Coulter (Fullerton, Calif., USA) in a Synchron Lxi ® automated 
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was also calculated for each urine sample. The urine ratio values 
used for the statistical analyses were the means of 2 or 3 single 
measurements. 
 Dual-Energy X-Ray Absorptiometry 
 Fat mass and bone density were measured via dual-energy X-
ray absorptiometry (DXA) using a Lunar Prodigy Primo device. 
The exposure to radiation was 0.4 mGy for the whole body (WB) 
and 0.9 mGy for the lumbar spine (LS). A 76-keV X-ray source of 
energy was used and the precision error of the test was 1%. All of 
the measurements were performed by the same technician to avoid 
interindividual variations. The fat mass index (FMI) was calcu-
lated as fat mass (kg)/height (m) 2 .
 The following bone densitometry variables were analyzed: WB 
and LS BMC (g) and bone mineral area (BMA; cm 2 ). The calcu-
lated variables were total and lumbar BMD (g/cm 2 ). Specific gen-
der z-scores were calculated using our own current data for WB 
and LS BMD. Children with values of BMD below –1 z-score were 
classified as osteopenic according to WHO recommendations 
 [31] . As the term ‘osteoporosis’ is controversial in children and 
adolescents  [32] , we will use the recommended term ‘low BMD for 
chronologic age’, rather than osteoporosis, to classify children with 
a BMD z-score below  − 2. 
 Bone mineral apparent density (BMAD), which is a volumetric 
vertebral size-independent parameter, was calculated as BMAD = 
LS BMC (g)/[LS BMA (cm 2 )] 1.5  [33] .
 Statistical Analysis 
 Data management and statistical analyses were carried out us-
ing the software package SPSS Statistics version 20.0 (IBM Corp., 
Armonk, N.Y., USA). Descriptive results were expressed as means 
(±SD). Students t tests or Mann-Whitney U tests were used for 
statistical comparison of quantitative variables between groups as 
appropriate. Pearson or Spearman correlation coefficients were 
used to test for linear associations among continuous variables. 
Differences in qualitative variables between groups were assessed 
using a χ 2 test. Multiple linear regression analyses were applied to 
test the effect of IHC on BMD with adjustment for confounding 
factors such as anthropometry, calcium intake, and physical activ-
ity. p < 0.05 was considered statistically significant.
 Ethical Considerations 
 This study was performed according to the Helsinki II declara-
tion and was approved by the local ethical committees. All parents 
or caregivers of the participating infants provided written in-
formed consent for participation in the study in accordance with 
the local ethical committees.
 Results 
 Study Sample 
 Screening for HC was offered to the Spanish subsample 
of 213 infants at 7 years of age from October 2009 to March 
2011. Of the eligible subjects, 185 agreed to participate and 
176 fully adhered to the protocol of the study (i.e. provid-
ed all necessary spot urine samples to be classified as
hypercalciuric or not) and were included. We analyzed 
whether the nutritional intervention conducted during 
the first year of life on these children could have had any 
influence on the key outcomes. No significant differences 
in calciuria or BMD were found between feeding types. A 
girl with a history of reflux nephropathy and microhema-
turia was excluded. Thus, 175 children (82% of the Span-
ish subsample) were finally included in the analyses. Of 
those 175 children, 167 underwent DXA as well.  Figure 1 
shows a flowchart of the participants in this study.
 Prevalence of HC 
 Thirty-three of the 175 studied children required a 
third urine sample. A total of 31 (17.7%) children were 
diagnosed with IHC. The calcium excretion ratio was 0.27 
± 0.07 in children diagnosed with IHC and 0.10 ± 0.05 
(mg/mg) in controls (p < 0.001). IHC occurred similarly 
in males (18.6%) and females (16.9%) (p = 0.762). All chil-
dren had had normal baseline concentrations of serum 
calcium and acid-base balances in previous analyses (data 
not shown). Family histories of lithiasis were similar in 
children with IHC (62.5%) and controls (52.5%) (p = 
0.375).
 Effect of Anthropometric and Dietary Variables on 
Calciuria 
 Anthropometric variables were similar in both study 
groups ( table  1 ). All children were well nourished and 
 Table 1.  Anthropometric and baseline characteristics of the par-







Gender (M/F) 70/74 16/15 0.762
Family history of lithiasis, 
n (%) 53 (52.5) 15 (62.5) 0.375
Age, years 7.02 ± 0.13 7.06 ± 0.06 0.132
Weight, kg 25.58 ± 4.67 25.52 ± 4.60 0.947
Weight z-score 0.66 ± 1.12 0.65 ± 1.10 0.966
Height, cm 122.71 ± 4.86 123.32 ± 4.44 0.522
Height z-score 0.26 ± 0.90 0.35 ± 0.82 0.614
BMI 16.90 ± 2.30 16.72 ± 2.45 0.692
BMI z-score 0.69 ± 1.17 0.60 ± 0.27 0.699
FMI 3.79 ± 1.96 3.52 ± 2.01 0.507
FMI z-score 4.76 ± 1.77 4.52 ± 1.83 0.502
 Values are presented as means ± SD unless otherwise stated.
A χ2 test was used for qualitative variables and Student’s t test
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consumed an unrestricted habitual diet. No significant 
correlations were found between weight, height, or BMI 
and calciuria (data not shown). 
 In addition, no effect of calcium intake on calciuria 
was detected. First, no significant correlation between to-
tal calcium intakes (mg/day × kg) and calciuria was found 
(r = –0.080, p = 0.310). Moreover, there were no differ-
ences between normocalciurics and IHC children in 
terms of their total calcium intake or their intake of cal-
cium from milk or dairy products ( table 2 ), with a mean 
calcium intake of 854.3 ± 398.6 mg/day. Both groups were 
similarly distributed within the quartiles of total calcium 
intake (34.6, 13.8, 25.8, and 25.8% for the 1st, 2nd, 3rd, 
and 4th quartiles of mg of calcium/day × kg). The calcium 
dietary source did not influence the calciuria levels. Cal-
cium intake estimations from milk or dairy products were 
similar in both groups ( table 2 ). The urea/creatinine ratio 
was associated with the UCa/UCr (r = 0.270, p < 0.001) 
but the urea/creatinine ratio did not significantly differ 
between the study groups (29.7 ± 7.0 vs. 28.5 ± 12.9 mg/
mg for IHC and controls, respectively; p = 0.081).
 Effect of Anthropometry, Dietary Variables, and 
Physical Activity on Bone Densitometry 
 Boys showed higher WB BMC (890.9 ± 119.6 vs. 852.9 
± 126.9 g, p = 0.048), WB BMA (1,055.8 ± 103.5 vs. 1,017.3 
Control





Total calcium intake, mg/day 866.3 ± 385.7 797.8 ± 456.2 0.179
Total calcium intake, mg/day × kg 33.3 ± 16.9 29.8 ± 17.9 0.327
Calcium intake from milk, mg/day × kg 15.2 ± 9.0 12.9 ± 8.8 0.248
Calcium intake from dairy products, mg/day × kg 16.3 ± 11.3 14.6 ± 9.5 0.422
 Values are presented as means ± SD. Student’s t test or the Mann-Whitney U test was 
used as appropriate for the quantitative variables.
Diagnosed with HC at 7 years:
n = 176 (86 boys and 90 girls)
Both bone densitometry and HC diagnosis at 7 years:
n = 167 (82 boys and 85 girls)
Excluded due to hematuria: n = 1
Did not agree to participate in complementary assessments: n = 28
Still in the study at 7 years: n = 213 (100 boys and 113 girls)
EU CHOP Spanish subsample
Finally included in the analysis:
n = 167 (82 boys and 85 girls)
Bone densitometry measurement at 
7 years: n = 179 (86 boys and 93 girls)
Did not provide urine samples to complete
the HC diagnosis: n = 9
Did not undergo DXA: n = 6
 Fig. 1. Flowchart of the participants in this 
study. 
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± 119.7 cm 2 , p = 0.029), and LS BMA (27.3 ± 2.8 vs. 26.0 
± 2.7 cm 2 , p = 0.003) as well as lower LS BMAD (0.13 ± 
0.02 vs. 0.14 ± 0.01 g/cm 3 , p = 0.014) than girls. However, 
among all of these variables, significant differences be-
tween genders disappeared when z-scores were analyzed.
 WB BMD z-scores and LS BMD z-scores were directly 
associated with all anthropometric variables ( fig. 2 ) and 
were not associated with the total calcium intake (mg/day 
× kg) or the urinary urea/creatinine ratio. The physical 
activity (PAQ-C) score was directly associated with the 
WB BMC (r = 0.201, p = 0.015) and the LS BMAD z-score 
(r = 0.375, p < 0.001) but not with BMD or the BMD z-
score. No differences were found between controls and 
IHC in terms of physical activity (2.85 ± 0.48 vs. 2.70 ± 
0.48 score points for controls and IHC children, respec-
tively; p = 0.141).




































































r = 0.441, p < 0.001
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 Fig. 2. Correlation between anthropomet-
ric variables and bone densitometry. WB 
BMD ( a ,  c ,  e ,  g ) and LS BMD ( b ,  d ,  f ,  h ) 
correlations with weight z-score, height z-
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 Effect of HC on Bone Densitometry 
 IHC children exhibited lower WB BMD compared to 
controls ( table 3 ). Differences between groups were bor-
derline significant as absolute values (0.84 ± 0.04 vs. 0.83 
± 0.04 g/cm 2 , p = 0.055) and significant when they were 
gender adjusted as z-scores (p = 0.040) ( table 3 ). No dif-
ferences were observed between study groups in any of 
the other bone densitometry-assessed variables ( table 3 ).
 Seven (22.6%) IHC children and 16 (11.9%) controls 
had a WB BMD z-score below –1. The relative risk was 
1.91 (95% CI 0.86–4.23, p = 0.113) and did not reach 
statistical significance. Three children (2 controls and 1 
IHC) showed WB BMD z-scores below –2 and could be 
categorized as low bone density for chronologic age. 
The prevalence of this feature was similar among IHC 
and controls (3.2 vs. 1.5% of the IHC and controls, re-
spectively, with a relative risk of 2.27; 95% CI 0.21–
24.19) but did not reach statistical significance (p = 
0.498) ( fig. 3 ).
 Simple linear regression analyses revealed no effect of 
total calcium intake, urinary urea/creatinine ratio, or 
physical activity (measured as the PAQ-C score) on the 
WB BMD z-score. Conversely, an IHC diagnosis as well 
as all anthropometric variables were able to modulate the 
WB BMD z-score (p = 0.044 for IHC and p < 0.001 for 
anthropometric variables). Therefore, we included IHC 
diagnosis and weight z-score (the most predictive of the 
anthropometric variables) in a multivariate linear regres-
sion model as independent variables and adjusted for oth-
er confounding variables to obtain the best model to ex-
plain the WB BMD z-score ( table 4 ). The effect of IHC 
diagnosis on the WB BMD z-score remained statistically 
significant even when we adjusted the model for the the-
oretically most relevant studied variables (i.e. physical ac-
tivity and calcium intake). However, the most predictive 
model was the one that included only anthropometry and 
IHC diagnosis. This model was able to explain up to 
18.7% of the WB BMD z-score variability ( table 4 ), where-
as the adjusted model (including also physical activity 
and calcium intake, which had no statistically significant 
effect) explained only up to 16.4%, showing no statistical 
significance among the adjusted variables.
 Discussion 
 As far as we know, this is the first study to demonstrate 
a reduction in BMD in children with asymptomatic IHC, 
which may have important implications for long-term 
bone health. One of the main strengths of our study is that 
we controlled the most important factors that modulate 
urinary calcium excretion and BMD.
 The IHC prevalence in our study sample was in the 
higher range of the already reported prevalences in Spanish 
children (7.8 and 16%)  [34, 35] . Studies in children have 
not conclusively demonstrated a clear difference between 
the different subtypes of HC (resorptive, renal, and absorp-
tive), overcoming classification modifications in the same 








LS (L1 to L4)
BMC, g 18.56 ± 3.10 18.85 ± 3.01 0.634
BA, cm2 26.40 ± 2.60 27.20 ± 3.50 0.144
BMD, g/cm2 0.70 ± 0.07 0.69 ± 0.08 0.587
BMD z-score 0.02 ± 1.06 –0.01 ± 0.84 0.900
BMAD, g/cm3 0.13 ± 0.02 0.13 ± 0.02 0.153
BMAD z-score 0.02 ± 0.98 –0.02 ± 0.96 0.158
WB
BMC, g 875.0 ± 129.6 857.1 ± 99.6 0.472
BA, cm2 1,036.4 ± 116.0 1,034.0 ± 103.7 0.915
BMD, g/cm2 0.84 ± 0.04 0.83 ± 0.04 0.055
BMD z-score 0.09 ± 0.99 –0.31 ± 0.88 0.040
 Values are presented as means ± SD. Student’s t test or the 





























 Fig. 3. Accumulated prevalence of osteopenia (WB BMD z-score 
lower than –1) (open bars) and low bone density for chronologic 
age (WB BMD z-score lower than –2) (closed bars) in control and 
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children over the years  [14] . Patients with resorptive HC 
present major bone damage, but this is present also in the 
other subtypes  [36, 37] . For this reason, we were interested 
in evaluating children with any subtype of IHC, and there-
fore we used a general protocol for HC diagnosis without 
performing specific tests to determine the different patho-
physiological subtypes described within IHC.
 Urinary Calcium Excretion Evaluation 
 Several factors such as age, body size, and the intake of 
a number of nutrients influence urinary calcium excre-
tion in humans  [38–40] . It is known that a positive asso-
ciation exists between BMI and urinary excretion of so-
dium, calcium, uric acid, and citrate. Furthermore, over-
weight has been associated with an increased risk of 
calcium stones in both adults and children with HC  [41] . 
In our study, we found no relationship between anthro-
pometric variables and calciuria, possibly because all chil-
dren were the same age and had similar anthropometric 
characteristics.
 The most important dietary factor affecting calciuria 
is calcium intake, but large epidemiological studies have 
shown that significant differences in dietary calcium in-
take have little influence on the level of calciuria in either 
normal subjects or those with kidney stones  [42] . In our 
study, children with IHC showed daily calcium intakes 
similar to those of controls, and there was no association 
between calcium intake and urinary excretion. On the 
other hand, a high consumption of animal proteins could 
cause acid overload, which would inhibit the renal reab-
sorption of calcium and increase its urinary excretion 
 [43] . To control the possible effect of protein intake on 
calciuria, we analyzed urinary urea as the urea/creatinine 
ratio has been demonstrated to be an accurate indicator 
of protein intake  [25, 26, 34] . Although we found a slight 
correlation between urea/creatinine and calciuria, both 
controls and IHC had similar urea excretion levels. There-
fore, we assumed no significant bias in the classification 
of children as IHC secondary to dietetic factors, as the 
intakes of calcium as well as proteins were similar in the 
two diagnosis groups.
 Influence of HC on Bone Health 
 In this study, we also controlled many of the factors 
that may influence BMD, such as anthropometric charac-
teristics, dietary factors, and physical activity. Through-
out childhood, the length and width of bones increase, the 
cortical thickness increases, and there is a dramatic in-
crease in bone mass as well as a significant increase in 
bone density. All of these processes are influenced by ge-
netic, hormonal, and environmental factors. The hor-
monal effect had little influence on our study because our 
children were all in the prepubertal stage. Adequate cal-
cium and vitamin D availability together with regular 
physical activity are among the most important environ-
mental factors for the optimal accrual of bone mineral 
mass and density  [44] . A meta-analysis of 19 randomized 
controlled trials including 2,859 healthy children aged 
3–18 years showed a positive effect of calcium supple-
mentation on the total body BMC with doses ranging be-
tween 300 and 1,200 mg/day  [45] . Moreover, an animal 
protein-rich diet produces an acid overload caused by 
mobilization of the bone buffer system, which favors a 
loss of calcium deposits, together with renal physiology 
changes that cause glomerular hyperfiltration and inhib-
it tubular reabsorption of calcium, thus increasing the 
calciuria. This complex mechanism causes a negative cal-
cium balance and bone loss  [15] . In relation to these di-
etetic factors, in our study we did not find associations 
between calcium and protein intake and BMD, probably 
because they were within the normal range for that age. 
 Table 4.  Effect of IHC on the WB BMD z-score
n Estimate 95% CI p R2
Model adjusted for anthropometry
Weight z-score 164 0.361 0.240 to 0.482 <0.001 0.187
IHC (yes vs. no) –0.379 –0.727 to –0.032 0.033
Model adjusted for anthropometry, physical activity, and calcium intake
Weight z-score 145 0.240 0.121 to 0.359 <0.001 0.164
IHC (yes vs. no) –0.351 –0.681 to –0.021 0.037
PAQ-C score –0.248 –0.023 to 0.519 0.072
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 On the other hand, it is well known that exercise exerts 
a positive effect on bone mass. Physical activity during 
early childhood and adolescence is an important predic-
tor of the bone mass peak, which may account for up to 
17% of the variance in BMD between individuals in their 
late 20s  [6] . In our study, physical activity levels were sim-
ilar in both groups (IHC and controls), but, as expected, 
we found direct associations between physical activity 
and WB BMC as well as with the LS BMAD z-score; there-
fore, we adjusted the effect of HC on BMD for physical 
activity in multivariate analyses.
 A low weight and a low BMI are well-documented risk 
factors for future fractures, whereas a high BMI appears 
to be protective. Body weight is positively associated with 
WB BMD in adults, possibly as a consequence of en-
hanced mechanical strain. Accordingly, we also observed 
an association between anthropometric variables and 
bone densitometry in the 7-year-old children, with weight 
being the most highly correlated variable.
 It is worth commenting that the LS BMD might be af-
fected by the above-mentioned factors in a different way 
than the rest of the body is not. LS BMD mainly consists 
of trabecular bone, whereas WB BMD consists of 80% 
cortical bone. Thus, LS BMD is mostly affected by weight 
bearing, whereas WB BMD is mostly affected by nutrition 
and physical activity. Our study was consistent with these 
characteristics and mechanisms based on the higher cor-
relations observed between anthropometric variables and 
LS versus WB densitometry ( fig. 2 ).
 It is well known that there is renal loss of calcium in 
patients with HC caused by a defect in the reabsorption of 
filtered calcium, even among children with increased in-
testinal absorption. This effect leads to a negative balance 
of calcium in most of these patients, which promotes bone 
loss  [46] . Bone loss in children with IHC can result from 
increased bone resorption, decreased bone formation, or 
both. The main mechanism is controversial, and several 
authors argue that bone loss is consistent with increased 
bone resorption and/or turnover and could be preco-
ciously detected in trabecular bone in the LS  [15] , but oth-
ers advocate the notion that the low BMD is due princi-
pally to a suppression of bone formation, especially in pa-
tients with absorptive HC. Therefore, a common finding 
in studies on IHC children is a frequent decrease in BMD. 
Thus, a current concern is the contribution of persistent 
HC to a diminished bone mass. In 1992, Perrone et al.  [17] 
examined 20 children with IHC resulting from increased 
intestinal absorption of calcium. Among these children, 4 
(20%) showed a reduced LS BMD. In a previous study, we, 
like other authors, observed a lower BMD in patients with 
sustained HC compared to cases with rare or intermittent 
HC  [17, 18] . In addition, different authors have reported 
inverse associations between BMD and age in patients 
with IHC  [16] . Thus, it seems that bone loss may be influ-
enced by the magnitude and the persistence of elevated 
calciuria, supporting the idea that prolonged periods of 
HC are needed to affect the bone structure. This may ex-
plain why children with asymptomatic HC, where the cal-
ciuria intensity is probably lower, would have less skeletal 
involvement. All of these features are relevant for the in-
terpretation of our results. We found a significant reduc-
tion of WB BMD z-scores among IHC children, with a 
slight reduction in the lumbar area that did not reach sta-
tistical significance compared to controls. This fact could 
be attributed to a possibly lower proportion of patients 
with resorptive IHC in our series (which is more symp-
tomatic than absorptive IHC) and therefore less trabecu-
lar bone involvement. The reported prevalence of osteo-
penia in symptomatic HC children ranges from 30 to 47% 
 [15] . We found a slightly lower prevalence of osteopenia 
(22%) probably because our IHC children were younger 
and asymptomatic. Despite the absence of a statistical dif-
ference between IHC and controls in the prevalence of 
serious bone demineralization (3.2 vs. 1.5%), the fact that 
the WB BMD z-scores of asymptomatic IHC children 
were lower at 7 years of age is of great importance due to 
the long-term possible consequences if HC persists. It is 
also noteworthy that most of the relevant factors affecting 
BMD were controlled in our study, and even analyses ad-
justing for those factors showed a reduced BMD in IHC 
children. Among those factors, the ones most related to 
BMD were anthropometry and physical activity. Our mul-
tivariate analyses demonstrated that those factors did not 
interfere with the effect of HC on bone mineralization.
 Strengths and Limitations 
 As previously stated, in our study we controlled results 
for the most relevant factors that modulate urinary calci-
um excretion and BMD. However, a limitation might be 
that we did not control the dietary intake of vitamin D and 
therefore we have to assume a similar effect in all children 
in our study which was conducted in the same Mediter-
ranean geographical area. We diagnosed HC including all 
physiopathological subtypes. As patients with resorptive 
HC present major bone damage, our selection of patients 
could have modulated our findings. Other limitations we 
have to assume are related to the single age and time point 
assessment. We included only 7-year-old children and 
performed evaluations as transversal observations. This 
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differences in bone mineralization between normocalciu-
rics and hypercalciurics disappeared or were enhanced at 
further ages. Despite this limitation, our aim was to detect 
bone affectation in an early age period, and for this reason 
we selected children in the prepubertal period.
 Conclusions 
 We found a nondepreciable 17% of IHC children among 
an apparently healthy population of 7-year-old children. 
IHC children showed reduced WB BMD z-scores, with 
22% of them at the osteopenic level. We think that screen-
ing for HC in school-aged children could be important be-
cause the reduction of bone mass seems to be precocious, 
already present in previously undiagnosed children, sug-
gesting that asymptomatic IHC could act as a detrimental 
factor influencing BMD in the future. The natural course 
of HC-associated low bone density requires further evalu-
ation. Longitudinal studies in this pediatric population will 
help us to address the significance of this prepubertal bone 
loss for the risk of fractures in adulthood.
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